| The human phenotype ontology in 2021 S Köhler, M Gargano, N Matentzoglu, LC Carmody, D Lewis-Smith, ... Nucleic acids research 49 (D1), D1207-D1217, 2021 | 786 | 2021 |
| AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ... Nature communications 10 (1), 3094, 2019 | 185 | 2019 |
| Assessing the landscape of STXBP1-related disorders in 534 individuals J Xian, S Parthasarathy, SM Ruggiero, G Balagura, E Fitch, K Helbig, ... Brain 145 (5), 1668-1683, 2022 | 61 | 2022 |
| Epilepsy care during the COVID‐19 pandemic JH Cross, CS Kwon, AA Asadi‐Pooya, G Balagura, P Gómez‐Iglesias, ... Epilepsia 62 (10), 2322-2332, 2021 | 59 | 2021 |
| Pharmacokinetics and drug interaction of antiepileptic drugs in children and adolescents G Iapadre, G Balagura, L Zagaroli, P Striano, A Verrotti Pediatric Drugs 20, 429-453, 2018 | 39 | 2018 |
| Fenfluramine for the treatment of Dravet syndrome and Lennox–Gastaut syndrome G Balagura, M Cacciatore, EA Grasso, P Striano, A Verrotti CNS drugs 34, 1001-1007, 2020 | 37 | 2020 |
| Emerging drugs for the treatment of Dravet syndrome F Brigo, P Striano, G Balagura, V Belcastro Expert Opinion on Emerging Drugs 23 (4), 261-269, 2018 | 33 | 2018 |
| Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants F Malerba, G Alberini, G Balagura, F Marchese, E Amadori, A Riva, ... Neurology: Genetics 6 (6), e528, 2020 | 31 | 2020 |
| Moving beyond sodium valproate: choosing the right anti-epileptic drug in children G Balagura, G Iapadre, A Verrotti, P Striano Expert opinion on pharmacotherapy 20 (12), 1449-1456, 2019 | 30 | 2019 |
| Loss of Wwox perturbs neuronal migration and impairs early cortical development M Iacomino, S Baldassari, Y Tochigi, K Kośla, F Buffelli, A Torella, ... Frontiers in Neuroscience 14, 644, 2020 | 29 | 2020 |
| New trends and most promising therapeutic strategies for epilepsy treatment A Riva, A Golda, G Balagura, E Amadori, MS Vari, G Piccolo, M Iacomino, ... Frontiers in neurology 12, 753753, 2021 | 28 | 2021 |
| Natural history study of STXBP1-developmental and epileptic encephalopathy into adulthood H Stamberger, D Crosiers, G Balagura, CM Bonardi, A Basu, G Cantalupo, ... Neurology 99 (3), e221-e233, 2022 | 26 | 2022 |
| Diagnostic approach to macrocephaly in children A Accogli, AF Geraldo, G Piccolo, A Riva, M Scala, G Balagura, ... Frontiers in Pediatrics 9, 794069, 2022 | 26 | 2022 |
| Epilepsy Course and Developmental Trajectories in STXBP1-DEE G Balagura, J Xian, A Riva, F Marchese, B Ben Zeev, L Rios, D Sirsi, ... Neurology: Genetics 8 (3), e676, 2022 | 25 | 2022 |
| Modeling seizures in the Human Phenotype Ontology according to contemporary ILAE concepts makes big phenotypic data tractable D Lewis‐Smith, PD Galer, G Balagura, H Kearney, S Ganesan, M Cosico, ... Epilepsia 62 (6), 1293-1305, 2021 | 17 | 2021 |
| Targeted re-sequencing in malformations of cortical development: genotype-phenotype correlations A Accogli, M Severino, A Riva, F Madia, G Balagura, M Iacomino, ... Seizure 80, 145-152, 2020 | 15 | 2020 |
| Emerging treatments for progressive myoclonus epilepsies A Riva, A Guglielmo, G Balagura, F Marchese, E Amadori, M Iacomino, ... Expert review of neurotherapeutics 20 (4), 341-350, 2020 | 15 | 2020 |
| An open retrospective study of a standardized cannabidiol based-oil in treatment-resistant epilepsy F Marchese, MS Vari, G Balagura, A Riva, V Salpietro, A Verrotti, R Citraro, ... Cannabis and cannabinoid research 7 (2), 199-206, 2022 | 14 | 2022 |
| STXBP1 Syndrome Is Characterized by Inhibition-Dominated Dynamics of Resting-State EEG SJ Houtman, HCA Lammertse, AA van Berkel, G Balagura, E Gardella, ... Frontiers in physiology 12, 775172, 2021 | 14 | 2021 |
| Adjunctive rufinamide in children with Lennox-Gastaut syndrome: a literature review G Balagura, A Riva, F Marchese, A Verrotti, P Striano Neuropsychiatric Disease and Treatment, 369-379, 2020 | 14 | 2020 |
